Marshall Wace LLP lessened its holdings in shares of FIGS, Inc. (NYSE:FIGS - Free Report) by 35.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,482,464 shares of the company's stock after selling 809,439 shares during the quarter. Marshall Wace LLP owned 0.87% of FIGS worth $9,176,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Sugar Maple Asset Management LLC acquired a new stake in shares of FIGS during the fourth quarter worth about $43,000. Blue Trust Inc. raised its holdings in FIGS by 380.0% during the 4th quarter. Blue Trust Inc. now owns 7,407 shares of the company's stock worth $51,000 after buying an additional 5,864 shares during the period. Cibc World Markets Corp bought a new position in FIGS in the fourth quarter valued at approximately $75,000. Senvest Management LLC acquired a new position in shares of FIGS in the fourth quarter valued at approximately $84,000. Finally, Lane & Associates LLC bought a new stake in shares of FIGS during the fourth quarter worth $86,000. 92.21% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several equities research analysts recently commented on FIGS shares. Morgan Stanley cut their price objective on shares of FIGS from $4.75 to $4.25 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Telsey Advisory Group reaffirmed a "market perform" rating and set a $7.00 price objective on shares of FIGS in a research report on Friday, February 28th. Finally, The Goldman Sachs Group dropped their target price on FIGS from $4.25 to $3.75 and set a "sell" rating on the stock in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, FIGS currently has an average rating of "Hold" and an average price target of $5.15.
Read Our Latest Research Report on FIGS
FIGS Stock Performance
NYSE:FIGS opened at $3.89 on Wednesday. FIGS, Inc. has a 52-week low of $3.57 and a 52-week high of $7.06. The company has a market cap of $631.39 million, a P/E ratio of 64.75, a P/E/G ratio of 31.62 and a beta of 1.18. The stock's 50-day simple moving average is $4.61 and its 200 day simple moving average is $5.36.
FIGS Profile
(
Free Report)
FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.
Featured Stories
Want to see what other hedge funds are holding FIGS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for FIGS, Inc. (NYSE:FIGS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider FIGS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FIGS wasn't on the list.
While FIGS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.